Is Selank legal? Australian, FDA and Russian status

Is Selank legal in Australia?

Australian law does not name Selank in the search made for this page, which leaves its status to general rules. A search of the October 2026 Poisons Standard (Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026, F2026L01327, dated 28 September 2026) found no entry for selank, tuftsin, TP-7 or its sequence on 14 October 2026, read on legislation.gov.au. The TGA says a peptide product that is a therapeutic good generally requires an ARTG entry or a specific exemption, approval or authority, that separate manufacturing and advertising requirements also apply, and that a 'research use only' label does not change whether a product is regulated as a therapeutic good (TGA, checked 14 October 2026). Australian law on peptides sets out the same exceptions. A missing entry is not permission.

The Poisons Standard sorts medicines and poisons into schedules, which are tiers of control. Australian law on peptides read the same instrument on 1 October 2026 and also found no individual entry for selank. It draws no conclusion about group headings, and neither does this page. Western Australia adds a state layer, set out in how the Poisons Standard reaches Western Australia.

Whether a product counts as a therapeutic good depends on what it contains, how it is promoted and what it is intended to do (TGA, Peptide products, updated 23 September 2026).

Evidence limits

What do these legal records not tell you?

The United States and Russian records further down are not Australian law. They are included because people ask about them.

Is Selank approved by the TGA?

No TGA page read for this page names Selank. The TGA's examples of unapproved peptide products are BPC-157, GHK-Cu, TB-500, retatrutide and CJC-1295 (TGA advisory, 13 April 2026). The TGA calls goods that are not on the ARTG (the Australian Register of Therapeutic Goods) 'unapproved' and says it has not assessed them for quality, safety or effectiveness (TGA, How we regulate therapeutic peptide products, checked 14 October 2026). Whether Selank appears on the ARTG was not checked in the register itself.

The TGA states that 'research use only' disclaimers do not change a product's regulatory status, permit importation or remove advertising or supply obligations (TGA advisory, 13 April 2026). A research label does not alter the records on this page, and the Selank reference material page describes research material, not a medicine. In a laboratory analysis of two suspicious preparations, Belgian analysts found Selank and Semax, and they built a method to detect ten such research peptides sold online; the finding shows presence in those two preparations and not how common they are (Vanhee et al., 2020).

Is Selank FDA approved?

No FDA approval record for Selank was found. A search of openFDA's Drugs@FDA data for the active-ingredient name selank returned 'No matches found', and DailyMed, the FDA's drug-label library, held no label for the drug name selank (both searched 14 October 2026). Semax returned no match in either source (openFDA; DailyMed). The FDA's briefing for its 23-24 July 2026 advisory committee describes semax as 'a registered drug in Russia' and weighs it only as a compounding bulk substance, and it sets aside a nominators' article on selank as 'out of the scope of this evaluation' (FDA briefing document, July 2026).

On the FDA's compounding page, 'Selank acetate (TP-7)' and 'Semax (heptapeptide)' sit in the same table of substances 'nominated but withdrawn', and both entries say the FDA lacks or has limited safety information (FDA, content current as of 22 April 2026). The Selank side-effects page quotes the Selank entry. A listing on that page is not an approval, and compounding is not the same as a registered product.

Why is Selank not FDA approved?

No FDA explanation was found in the sources searched for this page on 14 October 2026. The FDA says drug companies seeking to sell a drug in the United States must first test it, then send the agency evidence that it is safe and effective for its intended use (FDA, Development & Approval Process, checked 14 October 2026). The records searched show no approval, label or registered trial: Drugs@FDA and DailyMed hold no Selank record, and a ClinicalTrials.gov search for the term selank on 14 October 2026 returned only loosely matched records, none of which contains the word Selank. The FDA's compounding page adds that it 'lacks important information' on safety issues raised by selank acetate given to humans. A 2021 review calls Selank 'poorly studied' (Doyno and White, 2021).

Why no company has filed is not recorded in any source read for this page. A registration in Russia does not carry over to another country, so the Russian record below does not change the US position.

Is Selank a controlled substance in the United States?

The United States federal controlled-substance rules do not name Selank in the search made for this page. A search of the electronic Code of Federal Regulations for 'selank' returned no results on 14 October 2026, and a search for 'tuftsin' returned none (eCFR, Title 21 up to date as of 9 October 2026). The schedules sit in 21 CFR part 1308. Absence from the schedules does not settle how FDA drug rules treat Selank.

Is Selank approved in other countries?

Selank is registered in Russia as 0.15% nasal drops, according to the product label reproduced on the RLS drug encyclopaedia (page changed 15 July 2025). The label classes it under ATC code N05BX, 'other anxiolytics' (ATC is the World Health Organization's drug classification), and the label states it is dispensed without a prescription. A 2008 rat paper describes Selank as the working element of a drug that had 'completed the third phase of the clinical testing as a selective anxiolytic'; that is the paper's own description of earlier testing, not a result reported there (Sarkisova et al., Zhurnal Vysshei Nervnoi Deyatelnosti, 2008). A Russian registration does not carry over to any other country.

No record read for this page shows a registration in the European Union, the United Kingdom or Australia. That is a statement about the sources checked, not a search of every national register.

Is Selank banned in sport?

The WADA 2026 Prohibited List, in force from 1 January 2026, does not name Selank, Semax or tuftsin in the text searched on 14 October 2026. Its class S0 prohibits at all times any pharmacological substance not addressed elsewhere in the List that has no current approval by any governmental regulatory health authority for human therapeutic use. This page does not decide whether S0 reaches a substance registered in Russia.

Sport Integrity Australia says athletes are accountable for any prohibited substance in their system, no matter the source, and urges them to check substances through the Sport Integrity App (Sport Integrity Australia, 13 May 2026). The check here covers the 2026 text only.